FDA approves Pfizer's eczema ointment

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it had approved Pfizer Inc's Eucrisa ointment to treat mild-to-moderate eczema, or atopic dermatitis, in patients two years and older.